Goodwin Procter is serving as legal counsel to Korro Bio, Latham & Watkins is serving as Frequency Therapeutics’ legal counsel, and Davis Polk is serving as...
You must be a Standard 1 Year member to access this content.
Davis Polk & Wardwell is advising Centogene N.V., while Latham & Watkins is advising Lifera in the transaction. Centogene N.V., a life science company focused on...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the joint book-running managers in the offering. Editas Medicine, Inc. (Nasdaq: EDIT) announced the pricing of an underwritten offering of 12,500,000 shares of its...
You must be a Standard 1 Year member to access this content.
Davis Polk advised BofA Securities, Inc., SVB Securities LLC on the offering. Cooley LLP represented Oculis Holding in the offering. Vischer AG advised Oculis Holding for...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Morgan Stanley & Co. LLC and Wedbush Securities Inc. on the offering. TScan Therapeutics, a biopharmaceutical company, has announced a $140.6 million SEC-registered common...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the sales agents, RBC Capital Markets, LLC and Evercore Group L.L.C., on the transaction. Emergent BioSolutions Inc., an American multinational specialty biopharmaceutical company headquartered in...
You must be a Standard 1 Year member to access this content.
Davis Polk advised Forbion European Acquisition Corp. (FEAC), a SPAC, on the acquisition. Stikeman Elliott LLP served as Canadian legal counsel, Maples Group served as legal...
You must be a Standard 1 Year member to access this content.
Davis Polk advised the representatives of the initial purchasers in the offering and also advised the counterparties on capped call transactions. Bloom Energy Corporation (NYSE: BE)...
You must be a Standard 1 Year member to access this content.
Gibson Dunn, Loyens & Loeff and STvB Advocaten advised Schlumberger, while Davis Polk advised the representatives of the underwriters. Schlumberger Investment S.A. announced an SEC-registered debt...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis advised Integral Ad Science and entities affiliated with Vista Equity Partners, while Davis Polk advised the representatives of the underwriters. Integral Ad Science...
You must be a Standard 1 Year member to access this content.
Cooley advised ACELYRIN, and Davis Polk advised the joint book-running managers. ACELYRIN, INC. announced its upsized initial public offering of 34,500,000 shares of common stock at...
You must be a Standard 1 Year member to access this content.
Janssen advised Cellular Biomedicine Group CAR-T on the transaction. Cellular Biomedicine Group signed an exclusive collaboration and license agreement with Janssen Biotech, Inc., pursuant to which Janssen...
You must be a Standard 1 Year member to access this content.
